CCL2 Predicts Survival in Patients with Inoperable Hepatocellular Carcinoma Undergoing Selective Internal Radiotherapy
CCL2 may serve as a potential marker for patient survival after SIRT. The prediction of which HCC patients are likely to benefit from SIRT may be helpful in guiding therapeutic management.
Authors
- Florian Haag (ORCID: https://orcid.org/0009-0008-8167-0503)
- Maciej Pech (ORCID: https://orcid.org/0000-0002-7140-6775)
- Severin Gylstorff (ORCID: https://orcid.org/0009-0009-4327-5534)
- Borna Relja (ORCID: https://orcid.org/0000-0002-5625-8823)
- J. Bujok
Institutions
- Universität Ulm (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- University Medical Centre Mannheim (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Cancers
- Published
- 2024-08-12
- DOI
- https://doi.org/10.3390/cancers16162832
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37